A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 63,291 shares of ADPT stock, worth $296,834. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63,291
Previous 56,945 11.14%
Holding current value
$296,834
Previous $206,000 57.28%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.37 - $5.12 $21,386 - $32,491
6,346 Added 11.14%
63,291 $324,000
Q2 2024

Aug 14, 2024

BUY
$2.34 - $3.96 $133,251 - $225,502
56,945 New
56,945 $206,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $670M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.